NCPD

Recent findings indicate that hypercortisolism can be an underlying contributor to difficult-to-control type 2 diabetes (T2D), and it may occur with lower cortisol levels than noted in overt Cushing syndrome. In this program, expert faculty discuss new perspectives on the...
Free CE/CME
July 31, 2026
This online, on-demand virtual symposium brings together renowned experts in atopic dermatitis (AD). Janus kinase (JAK) inhibitors have emerged as an effective option for patients with moderate to severe AD, particularly those who have not responded adequately to conventional systemic...
Free CE/CME
July 31, 2026
This online, on-demand virtual symposium brings together renowned experts in atopic dermatitis. The OX40-OX40L interaction (2 co-stimulatory immune checkpoint molecules) plays a central role in the pathogenesis of atopic dermatitis. In this educational program, these experts review the evidence for...
Free CE/CME
August 28, 2026
This video-based program is designed for health care professionals to explore the utility of nonopioid therapies in managing acute pain through a unique perspective, putting the patient voice front and center. A patient lends their expertise to this program by...
Free CE/CME
August 29, 2026
The underlying pathophysiology of pulmonary arterial hypertension (PAH), a variant of pulmonary hypertension, originates in the pulmonary vasculature. Due to the rarity of PAH, few pediatric patients receive specialized therapy. In this video-based program, a pediatric pulmonologist and a pediatric...
Free CE/CME
August 30, 2026
In this activity, the faculty focus on the current and emerging therapeutic strategies for the holistic management of vitiligo. This engaging format is designed to help clinicians identify best practices in managing vitiligo and improve outcomes for their patients with...
Free CE/CME
August 29, 2026
Psoriasis (PsO) is a chronic, systemic inflammatory disease that affects 3% of US adults; it has been increasingly prevalent over the past years. The disorder is often characterized by chronicity, high grade of disability, and related comorbidities. Notably, biologic agents...
Free CE/CME
September 30, 2026
This activity is a video-based program in which 2 experts discuss the etiology of atherosclerotic cardiovascular disease (ASCVD) and the management of hyperlipidemia to reduce risk. Expert faculty focus on the role of elevated lipids in the development of ASCVD...
Free CE/CME
October 31, 2026
Spinal muscular atrophy (SMA) is a rare progressive neuromuscular disease that profoundly impacts patients and their families. Over the past decade, remarkable advances in genetic testing, disease-modifying therapies, and multidisciplinary care have transformed the outlook for individuals living with SMA....
Free CE/CME
October 31, 2026
This online, on-demand virtual symposium brings together renowned experts in neuromuscular disease, with a focus on generalized myasthenia gravis (gMG). In this educational program, these experts discuss the groundbreaking therapies now available that target the underlying autoimmune mechanisms more precisely...
Free CE/CME